Breast Implants Market Ensure to Reach US$ 2,338.6 Mn by 2027 End - Allergan, Mentor Worldwide, Sientra, Hansbiomed, Ideal Implant Incorporated and Groupe Sebbin SAS

Breast Implants Market accounted to US$ 1,475.7 Mn in 2018 and is expected to grow at a CAGR of 5.4% during the forecast period 2019 – 2027, to account to US$ 2,338.6 Mn by 2027.

Rising prevalence of breast cancer has led to an increase in the demand for breast implants. Breast cancer is prevalent across the globe with increase in number of women being diagnosed with breast cancer. The disease is common in developed as well as developing countries across the globe. As per the Breastcancer.org, in 2018, in the U.S., nearly 266,120 new cases of invasive breast cancer are expected to be diagnosed in women along with 63,960 new cases of non-invasive breast cancer.

Deaths rates due to breast cancer among the women in the US are high than other types of cancer. In 2018, nearly 40,920 women in the U.S. are expected to die due to breast cancer. The number of new cases for breast cancer in men are lesser as compared to women. Beastcancer.org stated that in 2018, about 2,550 new cases of invasive breast cancer are expected to be diagnosed in men.

Get PDF Sample Copy of this Report @ http://bit.ly/2tZQc1Q

Top Leading Market Players:

1. Allergan Plc
2. Mentor Worldwide LLC
3. Sientra Inc.
4. GC Aesthetics PLC
5. POLYTECH Health & Aesthetics GmbH
6. Hansbiomed Co. Ltd.
7. Ideal Implant Incorporated
8. Guangzhou Wanhe Plastic Materials Co., Ltd.
9. Establishment Labs S.A.
10. Groupe Sebbin SAS

Worldwide Breast Implants Market Analysis to 2027 is a specialized and in-depth study of the Breast Implants Industry with a focus on the global market trend. The report aims to provide an overview of global Breast Implants Market with detailed market segmentation by product/application and geography. The global Breast Implants Market is expected to witness high growth during the forecast period. The report provides key statistics on the Market status of the Breast Implants players and offers key trends and opportunities in the market.

The market for breast implants is also driven by new product launches and FDA approvals. Most of the market players are engaged in the manufacturing various types of breast implants offering maximum advantages and high quality. For instance, in January, 2018, Sientra, Inc. received the U.S. Food and Drug Administration (FDA) approval of the site-change PMA supplement for its contract manufacturer “Vesta” to manufacture Sientra’s silicone gel breast implants.

Moreover, In January, 2017, Allergan plc received approval from the FDA to market NATRELLE INSPIRA SoftTouch breast implants in the US. Additionally, in October 2017, Mentor Worldwide LLC announced the availability of MemoryGel Xtra breast implants in the US.

GLOBAL BREAST IMPLANTS – MARKET SEGMENTATION

By Product

• Silicon
• Saline

By Application

• Cosmetic Surgery
• Reconstructive Surgery

By Surface Type

• Smooth
• Textured

Purchase for Report @ http://bit.ly/2QXVNig

Reasons to Buy the Report :

• Learn about the driving factors, affecting the market growth.
• Imbibe the advancements and progress in the market during the forecast period.
• Understand where the market opportunities lies.
• Compare and evaluate various options affecting the market.
• Pick up on the leading market players within the market.
• Envision the restrictions and restrains that are likely to hamper the market.

Contact Us:

The Insight partners,
Phone: +1-646-491-9876
Email: sales@theinsightpartners.com
Website: www.theinsightpartners.com

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

This release was published on openPR.